| pubmed-article:21073773 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C0006274 | lld:lifeskim |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C0036085 | lld:lifeskim |
| pubmed-article:21073773 | lifeskim:mentions | umls-concept:C0598610 | lld:lifeskim |
| pubmed-article:21073773 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21073773 | pubmed:dateCreated | 2010-11-15 | lld:pubmed |
| pubmed-article:21073773 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073773 | pubmed:abstractText | We sought to determine whether inhaled 3% hypertonic saline (HS) reduces admission to hospital in ambulatory children with moderately severe viral bronchiolitis. Secondary objectives compared changes in respiratory scores before and after treatment and assessed the need for unscheduled medical intervention within 7 days. | lld:pubmed |
| pubmed-article:21073773 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21073773 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073773 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21073773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073773 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21073773 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:21073773 | pubmed:issn | 1481-8035 | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:RossiCarloC | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:FlavinMichael... | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:KuzikBrian... | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:KentStevenS | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:AdeleyeAdetay... | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:KwanCharisse... | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:ZielinskiDavi... | lld:pubmed |
| pubmed-article:21073773 | pubmed:author | pubmed-author:VegsundBjorn... | lld:pubmed |
| pubmed-article:21073773 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21073773 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:21073773 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21073773 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21073773 | pubmed:pagination | 477-84 | lld:pubmed |
| pubmed-article:21073773 | pubmed:dateRevised | 2011-10-5 | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:meshHeading | pubmed-meshheading:21073773... | lld:pubmed |
| pubmed-article:21073773 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:21073773 | pubmed:articleTitle | Effect of inhaled hypertonic saline on hospital admission rate in children with viral bronchiolitis: a randomized trial. | lld:pubmed |
| pubmed-article:21073773 | pubmed:affiliation | Department of Paediatrics, Royal Victoria Hospital, Barrie, Ontario, Canada. briankuzik@hotmail.com | lld:pubmed |
| pubmed-article:21073773 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21073773 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21073773 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21073773 | pubmed:publicationType | Multicenter Study | lld:pubmed |
